Targeted use of siRNA in animal models of hepatic damage: an innovative therapy for acute liver failure.
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
M Eugenia
ME
Guicciardi
Gregory J
GJ
Gores
D000208:Acute Disease; D000818:Animals; D020868:Gene Silencing; D018390:Gene Targeting; D017093:Liver Failure / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D034741:RNA, Small Interfering; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics / Q000378:metabolism
D034741:RNA, Small Interfering; D018124:Receptors, Tumor Necrosis Factor